FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078600 [Registered on: 26/12/2024] Trial Registered Prospectively
Last Modified On: 26/12/2024
Post Graduate Thesis  Yes 
Type of Trial  PMS 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effectiveness of Topical Tranexamic Acid in Decreasing During Operation And After Operation Bleeding After Nasal Surgery  
Scientific Title of Study   Effectiveness of Topical Tranexamic Acid in Reducing Intraoperative and Postoperative Bleeding Following Nasal Endoscopic Sinus Surgery: Randomized Controlled Trial  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Bhairavi Sharma 
Designation  Post graduate  
Affiliation  Aarupadai Veedu Medical College and Hospital 
Address  OPD number 9 DEPARTMENT OF OTORHINOLARYNGOLOGY AARUPADAI VEEDU MEDICAL COLLEGE KIRUMAMPAKKAM

Pondicherry
PONDICHERRY
607402
India 
Phone  9819814438  
Fax    
Email  bhairavisharma98@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  T.C.VIKRAM 
Designation  Associate Professor 
Affiliation  Aarupadai Veedu Medical College and Hospital 
Address  Opd number 9 Department of Otorhinolaryngology Aarupadai Veedu Medical College and Hospital Kirumampakkam
Opd number 9 Department of Otorhinolaryngology Aarupadai Veedu Medical College and Hospital Kirumampakkam
Pondicherry
PONDICHERRY
607402
India 
Phone    
Fax    
Email  drtcvikram@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Bhairavi Sharma 
Designation  Post graduate  
Affiliation  Aarupadai Veedu Medical College and Hospital 
Address  OPD number 9 DEPARTMENT OF OTORHINOLARYNGOLOGY AARUPADAI VEEDU MEDICAL COLLEGE KIRUMAMPAKKAM

Pondicherry
PONDICHERRY
607402
India 
Phone  9819814438  
Fax    
Email  bhairavisharma98@gmail.com  
 
Source of Monetary or Material Support  
Aarupadai Veedu Medical college and hospital PONDY CUDDALORE MAIN ROAD , KIRUMAMPAKKAM PONDICHERRY 607402  
 
Primary Sponsor  
Name  Dr.Bhairavi Sharma 
Address  b501 dheeraj gaurav ht2 2 off link road near infinity mall andheri west mumbai  
Type of Sponsor  Other [SELF ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bhairavi Sharma  Aarupadai Veedu Medical College and Hospital   Opd number 9 DEPARTMENT OF OTORHINOLARYNGOLOGY Pondy Cuddalore Main road Kirumampakkam Bahour, Kirumampakkam, Puducherry 607402
Pondicherry
PONDICHERRY 
9819814438

bhairavisharma98@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Human Ethical committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 3||Administration,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Normal Saline  It is going to be used in pre operative and post operative nasal packing i.e topically post endoscopic sinus surgeries  
Intervention  Tranexamic Acid   It is going to be used in pre operative and post operative nasal packing i.e topically post endoscopic sinus surgeries as compared to saline in the control group  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Adults of 18 years and above requiring endoscopic sinus surgery.
. Patients aged 18 and above attending ENT OPD in AVMC with conditions such as chronic rhinosinusitis with or without polyp , Antrochoanal polyp, nasal diseases requiring unilateral or bilateral endoscopic sinus surgery scheduled for nasal endoscopic sinus surgery. 
 
ExclusionCriteria 
Details  Known allergy to tranexamic acid.
2. History of thromboembolic events, Coagulopathy, or use of anticoagulant medications.
3. Significant medical comorbidities (e.g., cardiovascular diseases, renal
Impairment, with uncontrolled Diabetes and Hypertension).
4. Patients being operated for nasal tumour
5. Revision endoscopic nasal surgery
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1. To assess the effectiveness of topical tranexamic acid in reducing intraoperative bleeding and immediate post op bleeding in patients undergoing endoscopic sinus surgery.
2. To assess the intra operative surgical field using Boezarts scale in both TXA group and control group in Endoscopic Sinus Surgery.
 
Intra operative checked at
5 mins
15 mins
25 mins
35 mins

post operatively checked at

Immediate post operatively
6hrs post operatively
12 hrs post operatively
24 hrs post operatively

 
 
Secondary Outcome  
Outcome  TimePoints 
1. To detect the duration of surgery in both the groups   1. To detect the duration of surgery in both the groups ( noting time from start of surgery to the end )  
 
Target Sample Size   Total Sample Size="66"
Sample Size from India="66" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   31/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response (Others) -  data will be emailed to those interested from the following email id bhairavisharma98@gmail.com

  6. For how long will this data be available start date provided 24-06-2025 and end date provided 24-12-2028?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

This research outlines the design and methodology of a randomized controlled trial aimed at assessing the impact of topical tranexamic acid application preoperatively on bleeding outcomes during surgery, surgical field visibility, operative time, and postoperative complications in patients undergoing nasal endoscopic sinus surgery. Secondarily, it also seeks to resolve discrepancies between various studies related to the use of topical tranexamic acid intraoperatively and postoperatively. Patients fulfilling the inclusion criteria will be recruited and divided into two distinct groups: a control group and a test group. The test group will be given topical tranexamic acid in their nasal packs preoperatively and postoperatively, after which intraoperative and postoperative assessments will be conducted , similarly for control group standard practice will be performed and their intraoperative and postoperative bleeding will be assed.

 
Close